Industries > Pharma > Global Drug-Device Combination Market 2017-2027

Global Drug-Device Combination Market 2017-2027

Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings

PUBLISHED: 30 August 2017
PAGES: 151
PRODUCT CODE: PHA0230

Clear
WOOCS 2.2.1

The global drug-device combination market was valued at $137bn in 2016 and is projected to grow at a CAGR of 6.2% in the first half of the forecast period. In 2016, the market is dominated by the Transmucosal submarket which held 21% share of the drug-device combination market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 151 page report you will receive 124 charts – all unavailable elsewhere.

The 151-page report provides clear detailed insight into the global drug-device combination market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand new report today you stay better informed and ready to act.

Report Scope

Global Drug-Device Combination Market forecasts from 2017-2027

• Revenue forecast for the drug-device combination market by End-Users:
– Hospitals & clinics
– Emergency service centers
– Ambulatory surgical centers
– Home care settings

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• Revenue forecast for the drug-device combination market by Products:
– Drug eluting stents
– Photosensitizers
– Orthopaedic products
– Infusion pumps
– Wound care products
– Transmucosal products
– Transdermal patches
– Others

Each submarket is further divided by region: North America, Europe, Asia-Pacific and Rest of the World

• This report provides individual revenue forecasts from 2017-2027 for these regional and national markets:
North America: The U.S and Rest of North America
Europe: France, Germany, Italy, U.K, Spain, Russia and Rest of Europe
Asia-Pacific: China, India, Japan, and Rest of Asia-Pacific countries
– Rest of the world (RoW): Latin America, and Middle East and African countries

Global Drug-Device Combination Market 2017-2027

Each regional market is further divided by end-users and products

• This report discusses the leading companies in the global drug-device combination market:
– Medtronic
– Boston Scientific Corporation
– Stryker Corporation
– Ethicon Inc
– C.R. Bard Inc.
– Medline Industries Inc.
– Mylan Inc.
– Terumo Corporation
– Pinnacle Biologics Inc.
– W. L. Gore & Associates, Inc.

• This report discusses the drivers, restraints as well as porter’s five forces analysis of the global drug-device combination market

Visiongain’s study is intended for anyone requiring commercial analyses for the global drug-device combination market. You find data, trends and predictions.

Buy our report today Global Drug-Device Combination Market 2017-2027: Drug Eluting Stents, Photosensitizers, Orthopaedic Products, Infusion Pumps, Wound Care Products, Transmucosal Products, Transdermal Patches, Hospital & Clinics, Ambulatory Surgical Centres, Emergency Service Centres, Home Care Settings.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Global Drug-Device Combination Market 2017-2027


Download sample pages

Complete the form below to download your free sample pages for Global Drug-Device Combination Market 2017-2027


Latest Pharma news

Visiongain Publishes Big Data Analytics in Healthcare Market Report 2021-2031

Healthcare has never been more personalized and affordable to anyone. Digital consulting applications use artificial intelligence to provide medical advice based on customized medical history record reviews and general medical information derived from big data inferences.

13 May 2021

READ

Visiongain Publishes NGS-Based RNA Sequencing Market Report 2021-2031

The market is expected to be driven by key factors such as rising cancer prevalence, government funding support in genetic research and technological advancements taking place in the biological research field. In addition, the market is predicted to gain huge traction in the developing countries.

11 May 2021

READ

Visiongain Publishes Single-Use Bioreactors Market Report 2021-2031

Strong product portfolio in the market is one of the major factors accelerating the growth of the market as availability of variants in the single-use systems allows targeted users more options.

11 May 2021

READ

Visiongain Publishes ePharmacy Market Report 2021-2031

The growth in online shopping has been driven by a rapid rise in the number of smartphones, broadband connections and innovative payment products, although security remains the biggest concern. With the evolving market dynamics, merchants’ payment needs are also changing.

06 May 2021

READ

Categories